An evaluation protocol for subtype-specific breast cancer event prediction
- PMID: 21760900
- PMCID: PMC3132736
- DOI: 10.1371/journal.pone.0021681
An evaluation protocol for subtype-specific breast cancer event prediction
Abstract
In recent years increasing evidence appeared that breast cancer may not constitute a single disease at the molecular level, but comprises a heterogeneous set of subtypes. This suggests that instead of building a single monolithic predictor, better predictors might be constructed that solely target samples of a designated subtype, which are believed to represent more homogeneous sets of samples. An unavoidable drawback of developing subtype-specific predictors, however, is that a stratification by subtype drastically reduces the number of samples available for their construction. As numerous studies have indicated sample size to be an important factor in predictor construction, it is therefore questionable whether the potential benefit of subtyping can outweigh the drawback of a severe loss in sample size. Factors like unequal class distributions and differences in the number of samples per subtype, further complicate comparisons. We present a novel experimental protocol that facilitates a comprehensive comparison between subtype-specific predictors and predictors that do not take subtype information into account. Emphasis lies on careful control of sample size as well as class and subtype distributions. The methodology is applied to a large breast cancer compendium involving over 1500 arrays, using a state-of-the-art subtyping scheme. We show that the resulting subtype-specific predictors outperform those that do not take subtype information into account, especially when taking sample size considerations into account.
Conflict of interest statement
Figures





























Similar articles
-
Breast cancer subtype predictors revisited: from consensus to concordance?BMC Med Genomics. 2016 Jun 3;9(1):26. doi: 10.1186/s12920-016-0185-6. BMC Med Genomics. 2016. PMID: 27259591 Free PMC article.
-
Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization.BMC Cancer. 2011 Apr 18;11:143. doi: 10.1186/1471-2407-11-143. BMC Cancer. 2011. PMID: 21501481 Free PMC article. Clinical Trial.
-
Module-based outcome prediction using breast cancer compendia.PLoS One. 2007 Oct 17;2(10):e1047. doi: 10.1371/journal.pone.0001047. PLoS One. 2007. PMID: 17940611 Free PMC article.
-
Breast cancer prognosis signature: linking risk stratification to disease subtypes.Brief Bioinform. 2019 Nov 27;20(6):2130-2140. doi: 10.1093/bib/bby073. Brief Bioinform. 2019. PMID: 30184043 Review.
-
The Complex Subtype-Dependent Role of Connexin 43 (GJA1) in Breast Cancer.Int J Mol Sci. 2018 Feb 28;19(3):693. doi: 10.3390/ijms19030693. Int J Mol Sci. 2018. PMID: 29495625 Free PMC article. Review.
Cited by
-
Reuse of public genome-wide gene expression data.Nat Rev Genet. 2013 Feb;14(2):89-99. doi: 10.1038/nrg3394. Epub 2012 Dec 27. Nat Rev Genet. 2013. PMID: 23269463 Review.
-
A pathway-based classification of breast cancer integrating data on differentially expressed genes, copy number variations and microRNA target genes.Mol Cells. 2012 Oct;34(4):393-8. doi: 10.1007/s10059-012-0177-0. Epub 2012 Sep 13. Mol Cells. 2012. PMID: 22983731 Free PMC article.
-
A novel network regularized matrix decomposition method to detect mutated cancer genes in tumour samples with inter-patient heterogeneity.Sci Rep. 2017 Jun 6;7(1):2855. doi: 10.1038/s41598-017-03141-w. Sci Rep. 2017. PMID: 28588243 Free PMC article.
-
A data similarity-based strategy for meta-analysis of transcriptional profiles in cancer.PLoS One. 2013;8(1):e54979. doi: 10.1371/journal.pone.0054979. Epub 2013 Jan 29. PLoS One. 2013. PMID: 23383020 Free PMC article.
-
Identifying global expression patterns and key regulators in epithelial to mesenchymal transition through multi-study integration.BMC Cancer. 2017 Jun 26;17(1):447. doi: 10.1186/s12885-017-3413-3. BMC Cancer. 2017. PMID: 28651527 Free PMC article.
References
-
- van't Veer L, Dai H, van de Vijver M, He Y, Hart A, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 2002;415:530. - PubMed
-
- Weigelt B, Baehner FL, Reis-Filho JS. The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade. Journal of Pathology. 2010;220:263–280. - PubMed
-
- Perou C, Sørlie T, Eisen M, van de Rijn M, Jeffrey S, et al. Molecular portraits of human breast tumours. Nature. 2000;406:747–752. - PubMed
-
- Desmedt C, Haibe-Kains B, Wirapati P, Buyse M, Larsimont D, et al. Biological processes associated with breast cancer clinical outcome depend on the molecular subtypes. Clinical Cancer Research. 2008;14:5158. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials